What company developed ruxolitinib?

Who developed ruxolitinib?

Ruxolitinib was developed by Incyte Corporation and is marketed in the US under the brand name Jakafi (ruxolitinib) for certain myeloproliferative neoplasms. [1]

Was ruxolitinib originally an Incyte drug?

Yes. Incyte is the company that created the ruxolitinib program and developed the drug to clinical use. [1]

Where can I verify the developer from a patent database?

You can cross-check ruxolitinib’s origin and related patent information using DrugPatentWatch.com. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/in/cycl/var?query=ruxolitinib